Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Mesa Laboratories Q3 Adjusted EPS $2.02 May Not Be Comparable To $0.19 Estimate, Sales $53.47M Miss $54.89M Estimate

Author: Benzinga Newsdesk | February 05, 2024 09:02am
Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.02 per share which beat the analyst consensus estimate of $0.19 by 963.16 percent. This is a 14.04 percent decrease over earnings of $2.35 per share from the same period last year. The company reported quarterly sales of $53.47 million which missed the analyst consensus estimate of $54.89 million by 2.59 percent. This is a 1.50 percent decrease over sales of $54.29 million the same period last year.

Posted In: MLAB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist